Does Ozempic Double the Risk of Eye Disease? 6 Key Findings You Need to Know

Ozempic, a popular medication for type 2 diabetes and weight management, has been making headlines—not just for its effectiveness but also for potential side effects. Recent studies suggest a possible link between Ozempic and non-arteritic anterior ischemic optic neuropathy (NAION), a rare but serious eye disease that can lead to permanent vision loss. If you’re taking Ozempic or considering it, it’s essential to understand the risks. Here are six key findings from the latest research.

1. Ozempic May More Than Double the Risk of NAION

Two large studies from the University of Southern Denmark (SDU) found that Ozempic users had more than twice the risk of developing NAION compared to those on other diabetes medications. NAION occurs when blood flow to the optic nerve is restricted, leading to sudden vision loss.

2. The Risk Is Higher Among Type 2 Diabetics

The research focused on type 2 diabetes patients, revealing that those taking Ozempic had a significantly higher incidence of NAION than those on alternative treatments. While Ozempic has been widely prescribed for weight loss, it’s unclear whether non-diabetic users face the same level of risk.

3. The Danish Studies Reviewed Over 450,000 Patients

These findings aren’t based on a small sample. One study analyzed data from 424,000 type 2 diabetes patients, while another reviewed over 44,000 Danish diabetics and 16,000 Norwegian patients using Ozempic between 2018 and 2024. The results indicate a consistent pattern of increased risk.

4. Ozempic’s Manufacturer Stands by Its Safety Profile

Despite the alarming findings, Novo Nordisk, the maker of Ozempic, insists that the drug remains safe and effective. The company acknowledges the studies but argues that the overall benefit-risk balance of semaglutide (the active ingredient in Ozempic) remains unchanged.

5. The FDA and European Regulators Are Investigating

Due to these findings, the Danish Medicines Agency has requested that the European Pharmacovigilance Risk Assessment Committee (PRAC) review the data. This could lead to regulatory changes or new safety warnings for Ozempic users in Europe and possibly the U.S.

6. NAION Is Irreversible – Early Detection Is Key

NAION causes painless, sudden vision loss in one eye, and no cure exists. Patients who experience blurred vision, sudden blind spots, or any changes in their eyesight should seek immediate medical attention. If you’re on Ozempic, scheduling regular eye exams to monitor for early warning signs is crucial.

What Should You Do If You’re Taking Ozempic?

If you’re currently using Ozempic for diabetes or weight loss, don’t panic—but do stay informed. Speak with your doctor about alternative medications if you’re at risk for eye disease, and schedule routine eye check-ups to protect your vision.

Concerned About Your Health? We Can Help!

At EndoSlim Clinic by Atlantic Gastroenterology in Brooklyn, NY, we prioritize patient safety and stay current with the latest medical research. If you’re taking Ozempic and have concerns about your eye health, diabetes management, or overall wellness, schedule a consultation today. Call us at 718 521-2840 to speak with our experts and get personalized guidance on your treatment options.

Share this Article